B cells in renal transplantation: Pathological aspects and therapeutic interventions

14Citations
Citations of this article
40Readers
Mendeley users who have this article in their library.

This article is free to access.

Abstract

B cells are vital in renal transplantation. B2 cells are part of the adaptive immune system. Activated B cells mature into plasma cells or memory B cells: their life spans can be prolonged by niches. B cells have a wide variety of functions: antibody production, antigen presentation, cytokine production and shaping of the splenic architecture. These functions play a vital role in graft rejection, both T cell-mediated rejection and antibody-mediated rejection. Markers of B cell activity include intragraft B cell infiltration, C4d deposition and circulating donor-specific antibodies. Many therapeutic options target B cells or plasma cells. As greater understanding is gained of their appropriate use, and new agents are developed, we should see prolonged graft survival and reduced graft rejection. © The Author 2011. Published by Oxford University Press on behalf of ERA-EDTA. All rights reserved.

Cite

CITATION STYLE

APA

Barnett, N., Dorling, A., & Mamode, N. (2011). B cells in renal transplantation: Pathological aspects and therapeutic interventions. Nephrology Dialysis Transplantation, 26(3), 767–774. https://doi.org/10.1093/ndt/gfq716

Register to see more suggestions

Mendeley helps you to discover research relevant for your work.

Already have an account?

Save time finding and organizing research with Mendeley

Sign up for free